POST-COVID19
DEPRESSION
DR. MD. SAIDUZZAMAN (MUNNA)
MEDICAL OFFICER
DEPARTMENT OF NEUROLOGY,
MYMENSINGH MEDICAL COLLEGE
HOSPITAL.
COVID19 UPDATE (13/12/2021)
Worldwide: Affected- 270,488,382
Death- 5,324,116.
Bangladesh: Affected- 1,579,325
Death- 28,028.
Bangladesh is in 31st position in terms of death.
DEPRESSION
 Depression is a mood disorder that causes a persistent feeling of
sadness and loss of interest.
 It is diagnosed by DSM-5 criteria.
DSM-5 CRITERIA
 Depressed mood (subjective/observed)
 Loss of interest or pleasure.
 Change in weight or appetite.
 Insomnia or hypersomnia
 Psychomotor retardation or agitation
 Fatigue
 Worthlessness or guilt
Impaired concentration
Suicidal ideation or attempt.
POST COVID19 DEPRESSION
 Depressive symptoms among COVID19 survivors.
Significantly increases morbidity and mortality.
 Depression may involve others including relatives of
COVI19 patients and health professionals.
 May start immediately after infection and may persist
for weeks to months.
Psychiatric consequences of COVID19:
 Post-traumatic stress disorder (PTSD)- 28%
 Depression- 31%
 Anxiety- 42%
 Obsessive–compulsive symptoms- 20%
Predisposing factors:
 Severe acute symptoms.
 Previous psychiatric disorder.
 Prolonged hospitalization including ICU.
 Loss of family members and friends.
 Residual symptoms.
 Associated medical conditions.
 Social isolation and financial crisis.
PATHOGENESIS
 Post COVID19 depression occurs due to Neurobiological
Damage.
 It is the net result of-
- Systemic inflammation,
- Cerebral hypoxia,
- Neuroinflammation.
CONSEQUENCES..
 Reduced performances.
 Financial problems.
 Household crisis.
 Sleep disturbance.
 Suicide.
DIAGNOSIS
 Diagnosis is suspected on clinical backgrounds.
 Differentials should be excluded with appropriate
investigations.
 Suicidal ideation and attempts should be addressed
appropriately.
 Hospitalization may be needed in major depressive
disorder.
 Psychiatric evaluation- daily moods, behaviors and
lifestyle habits.
 Physical signs-
- Back pain
- Headache
- Joint pain
- Limb pain
- Gut problems
MEDICAL CONDITIONS TO BE EXCLUDED…
 Anaemia due to any cause
 Hypothyroidism
 Diabetes Mellitus
 Heart failure
 CKD
 Malignancy
 Drugs and toxins- Steroids, Alcohol.
 Critical illness myopathy and neuropathy.
INVESTIGATIONS
• FBC, PBF
• Blood sugar
• Chest x-ray
• Organ function tests- LFT, RFT, TFT
• ECG, Echocardiography
• CPK
• NCS and EMG
TREATMENT
 Timely referral to psychiatrist.
 Treatment options are:
- Psychotherapy
- Drug therapy
- Other therapies
 Psychotherapy includes- Cognitive Therapy, Behavioral Therapy,
Cognitive-Behavioral Therapy, Interpersonal Therapy.
TREATMENT…….DRUG THERAPY
 Tricyclic Antidepressants (TCA)- Amitriptyline,
Nortriptyline, Imipramine, Mirtazapine.
 Selective Serotonin Re-uptake Inhibitor (SSRI)- Sertraline,
Citalopram, Escitalopram, Fluoxetine, Paroxetine.
 Selective Norepinephrine Re-uptake Inhibitor (SNRI)-
Milnacipran, Levomilnacipran, Venlafaxine, Duloxetine.
TREATMENT…… OTHER THERAPIES
 Electroconvulsive therapy
 Transcranial Magnetic Stimulation (TMS)
 Deep Brain Stimulation (DBS)
 Vagus Nerve Stimulation (VNS)
PREVENTION
 Early treatment of COVID19 symptoms.
 Adequate treatment of associated medical conditions.
 Treatment of previous psychiatric conditions.
 Physical isolation, not social isolation.
 Psychological support.
 Financial support.
Post covid depression

Post covid depression

  • 1.
    POST-COVID19 DEPRESSION DR. MD. SAIDUZZAMAN(MUNNA) MEDICAL OFFICER DEPARTMENT OF NEUROLOGY, MYMENSINGH MEDICAL COLLEGE HOSPITAL.
  • 2.
    COVID19 UPDATE (13/12/2021) Worldwide:Affected- 270,488,382 Death- 5,324,116. Bangladesh: Affected- 1,579,325 Death- 28,028. Bangladesh is in 31st position in terms of death.
  • 3.
    DEPRESSION  Depression isa mood disorder that causes a persistent feeling of sadness and loss of interest.  It is diagnosed by DSM-5 criteria.
  • 4.
    DSM-5 CRITERIA  Depressedmood (subjective/observed)  Loss of interest or pleasure.  Change in weight or appetite.  Insomnia or hypersomnia  Psychomotor retardation or agitation  Fatigue  Worthlessness or guilt Impaired concentration Suicidal ideation or attempt.
  • 5.
    POST COVID19 DEPRESSION Depressive symptoms among COVID19 survivors. Significantly increases morbidity and mortality.  Depression may involve others including relatives of COVI19 patients and health professionals.  May start immediately after infection and may persist for weeks to months.
  • 6.
    Psychiatric consequences ofCOVID19:  Post-traumatic stress disorder (PTSD)- 28%  Depression- 31%  Anxiety- 42%  Obsessive–compulsive symptoms- 20%
  • 8.
    Predisposing factors:  Severeacute symptoms.  Previous psychiatric disorder.  Prolonged hospitalization including ICU.  Loss of family members and friends.  Residual symptoms.  Associated medical conditions.  Social isolation and financial crisis.
  • 9.
    PATHOGENESIS  Post COVID19depression occurs due to Neurobiological Damage.  It is the net result of- - Systemic inflammation, - Cerebral hypoxia, - Neuroinflammation.
  • 10.
    CONSEQUENCES..  Reduced performances. Financial problems.  Household crisis.  Sleep disturbance.  Suicide.
  • 11.
    DIAGNOSIS  Diagnosis issuspected on clinical backgrounds.  Differentials should be excluded with appropriate investigations.  Suicidal ideation and attempts should be addressed appropriately.  Hospitalization may be needed in major depressive disorder.
  • 12.
     Psychiatric evaluation-daily moods, behaviors and lifestyle habits.  Physical signs- - Back pain - Headache - Joint pain - Limb pain - Gut problems
  • 13.
    MEDICAL CONDITIONS TOBE EXCLUDED…  Anaemia due to any cause  Hypothyroidism  Diabetes Mellitus  Heart failure  CKD  Malignancy  Drugs and toxins- Steroids, Alcohol.  Critical illness myopathy and neuropathy.
  • 14.
    INVESTIGATIONS • FBC, PBF •Blood sugar • Chest x-ray • Organ function tests- LFT, RFT, TFT • ECG, Echocardiography • CPK • NCS and EMG
  • 15.
    TREATMENT  Timely referralto psychiatrist.  Treatment options are: - Psychotherapy - Drug therapy - Other therapies  Psychotherapy includes- Cognitive Therapy, Behavioral Therapy, Cognitive-Behavioral Therapy, Interpersonal Therapy.
  • 16.
    TREATMENT…….DRUG THERAPY  TricyclicAntidepressants (TCA)- Amitriptyline, Nortriptyline, Imipramine, Mirtazapine.  Selective Serotonin Re-uptake Inhibitor (SSRI)- Sertraline, Citalopram, Escitalopram, Fluoxetine, Paroxetine.  Selective Norepinephrine Re-uptake Inhibitor (SNRI)- Milnacipran, Levomilnacipran, Venlafaxine, Duloxetine.
  • 17.
    TREATMENT…… OTHER THERAPIES Electroconvulsive therapy  Transcranial Magnetic Stimulation (TMS)  Deep Brain Stimulation (DBS)  Vagus Nerve Stimulation (VNS)
  • 18.
    PREVENTION  Early treatmentof COVID19 symptoms.  Adequate treatment of associated medical conditions.  Treatment of previous psychiatric conditions.  Physical isolation, not social isolation.  Psychological support.  Financial support.